{"description":"Other Adverse Events summarizes the non-serious occurrences of adverse events that exceed the indicated frequency threshold.","eventGroups":[{"deathsNumAffected":67,"deathsNumAtRisk":116,"description":"Participants received blinatumomab as a continuous intravenous infusion at a constant flow rate of 15 μg/m²/day over 28 days followed by an infusion-free period of 14 days for up to 4 cycles of treatment.","id":"EG000","otherNumAffected":111,"otherNumAtRisk":116,"seriousNumAffected":73,"seriousNumAtRisk":116,"title":"Blinatumomab"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":116}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":116}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":116}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":116}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":27,"numAtRisk":116}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":116}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":30,"numAtRisk":116}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":27,"numAtRisk":116}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":99,"numAtRisk":116}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"Device related infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":116}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"Blood immunoglobulin G decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"C-reactive protein increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":116}],"term":"Weight increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":116}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":116}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":116}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":116}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":116}],"term":"Aphasia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":116}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":44,"numAtRisk":116}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"Paraesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":28,"numAtRisk":116}],"term":"Tremor"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":116}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":116}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":116}],"term":"Night sweats"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":116}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":116}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":116}],"term":"Hypotension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Bone marrow failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":116}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Sinus bradycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Sinus tachycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Gastrointestinal haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Device issue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Device malfunction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Gait disturbance"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Infusion site extravasation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Product contamination microbial"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Puncture site pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":116}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Thrombosis in device"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Hepatotoxicity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Cytokine release syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Hypersensitivity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Acinetobacter bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Atypical pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Bacterial infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Bronchopneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Bronchopulmonary aspergillosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Cystitis klebsiella"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":116}],"term":"Device related infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"H1N1 influenza"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Osteomyelitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Sinusitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":116}],"term":"Staphylococcal infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Urinary tract infection staphylococcal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Accidental overdose"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Incision site haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Infusion related reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":116}],"term":"Overdose"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Post lumbar puncture syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Spinal fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Subdural haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Thermal burn"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Blood bilirubin increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Body temperature increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":116}],"term":"C-reactive protein increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Hepatic enzyme increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Liver function test abnormal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Prothrombin time prolonged"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Kaposi's sarcoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"Aphasia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Ataxia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Cognitive disorder"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Dysarthria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":116}],"term":"Encephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Generalised tonic-clonic seizure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":116}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Intention tremor"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Leukoencephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Motor dysfunction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Paraesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":116}],"term":"Seizure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":116}],"term":"Tremor"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Agitation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Confusional state"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Disorientation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Dermatitis contact"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Thrombosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 18.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":116}],"term":"Vena cava thrombosis"}],"timeFrame":"All-cause mortality is reported from enrollment until the end of the follow-up period; median (minimum, maximum) time on study was 33.8 (1, 62) months. Adverse events are reported from the first dose of blinatumomab until 30 days after last dose; the median treatment duration was 55 days."}